News
-
Andrew’s Story: “A Clinical Trial Gave Me a Second Chance”
Read more: Andrew’s Story: “A Clinical Trial Gave Me a Second Chance”Andrew Stanley, 67, from Milton Keynes, had heartburn for years. He never thought much of it. Then in…
-
MP Shares Personal Experience of Oesophageal Cancer in Westminster Debate
Read more: MP Shares Personal Experience of Oesophageal Cancer in Westminster DebateIn January 2026, Patrick Hurley, MP for Southport, spoke in a Westminster Hall debate on Less Survivable Cancers,…
-
Late Diagnosis of Oesophageal Cancer Has Risen Sharply
Read more: Late Diagnosis of Oesophageal Cancer Has Risen SharplyThe proportion of oesophageal cancer cases diagnosed at the most advanced stage has increased significantly over the past…
-
Oesophageal Cancer Awareness Month 2026: Know the Symptoms
Read more: Oesophageal Cancer Awareness Month 2026: Know the SymptomsFebruary is Oesophageal Cancer Awareness Month. OCHRE is joining charities across the UK to help people understand the…
-
Breaking the Silence: Our Campaign for Oesophageal Cancer Awareness Month
Read more: Breaking the Silence: Our Campaign for Oesophageal Cancer Awareness MonthIt’s Oesophageal Cancer Awareness Month in the UK, and we’re planning to deliver a month-long awareness campaign that…
-
Mighty Oaks from Little Acorns Grow: Introducing the ACORN Research Initiative
Read more: Mighty Oaks from Little Acorns Grow: Introducing the ACORN Research InitiativeOCHRE and its partners aim to transform OSCC research in the UK and bring new hope to patients facing this…
-
OCHRE Trustee to Take on Great Wall of China Challenge in Memory of Founding Father
Read more: OCHRE Trustee to Take on Great Wall of China Challenge in Memory of Founding FatherSue Kee prepares for epic fundraising trek to honour her late father Gordon Kee, one of OCHRE’s original…
-
OCHRE Funds Groundbreaking Research into ‘Forgotten Cancer’
Read more: OCHRE Funds Groundbreaking Research into ‘Forgotten Cancer’Thanks to the incredible generosity of our supporters, OCHRE is providing over £300,000 to fund this vital research…